Fruquintinib in Patients With Metastatic Colorectal Cancer
Abroad (travel likely)Recruiting
Conditions
Metastatic Colorectal Cancer (mCRC)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Onkologische Schwerpunktpraxis, Hanover, Lower Saxony, Germany
Contact: Study coordinator (Dr. med. von der Heyde) · info@onkologie-am-raschplatz.de · +49 511311660Contact: Principal Investigator (Dr. med. von der Heyde)
Study leads
Professor Dr. med. Sebastian Stintzing
Principal Investigator
Charité Campus Mitte Medizinische Klinik Hämatologie/Onkologie und Tumorimmunologie